April 16, 2025 - 02:52

It’s getting hard to tell which is more pathetic: this year’s crop of mayoral candidates, or the city’s system for electing one of them. As the election season heats up, the shortcomings of New York City's Campaign Finance Board have come under intense scrutiny. The Board, which is supposed to provide a fair and transparent financial landscape for candidates, has drawn criticism for its inconsistent decisions and lack of support for prominent figures like Mayor Eric Adams and former Governor Andrew Cuomo.
Candidates are finding themselves navigating a confusing and often frustrating financial framework that seems to favor some while sidelining others. This has led to questions about the integrity of the electoral process and whether the current system truly serves the interests of the voters. As the mayoral race continues, the discontent surrounding the campaign finance structure is likely to overshadow the candidates themselves, raising concerns about the future of governance in the city. Voters are left wondering if they can trust the system to deliver a fair election.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...